Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Thermodynamic properties and glass transition temperature of roasted and unroasted carob (Ceratonia siliqua L.) powder.

Červenka L, Stępień A, Frühbauerová M, Velichová H, Witczak M.

Food Chem. 2019 Dec 1;300:125208. doi: 10.1016/j.foodchem.2019.125208. Epub 2019 Jul 19. No abstract available.

PMID:
31349097
2.
3.

Intraventricular placement of a spring expander does not attenuate cardiac atrophy of the healthy heart induced by unloading via heterotopic heart transplantation.

Pokorný M, Mrázová I, Kubátová H, Piťha J, Malý J, Pirk J, Maxová H, Melenovský V, Šochman J, Sadowski J, Červenka L, Čermák Z, Volenec K, Netuka I.

Physiol Res. 2019 Jun 6. [Epub ahead of print]

4.

The absence of sympathoexcitation during the development of hypertension in Cyp1a1 Ren-2 transgenic rats.

Zicha J, Hojná S, Kopkan L, Červenka L, Vaněčková I.

Physiol Res. 2019 Apr 30;68(2):329-334.

5.

Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive Ren-2 Transgenic Rats.

Hrdlička J, Neckář J, Papoušek F, Husková Z, Kikerlová S, Vaňourková Z, Vernerová Z, Akat F, Vašinová J, Hammock BD, Hwang SH, Imig JD, Falck JR, Červenka L, Kolář F.

Front Pharmacol. 2019 Mar 1;10:159. doi: 10.3389/fphar.2019.00159. eCollection 2019.

6.

Pharmacological Blockade of Soluble Epoxide Hydrolase Attenuates the Progression of Congestive Heart Failure Combined With Chronic Kidney Disease: Insights From Studies With Fawn-Hooded Hypertensive Rats.

Vacková Š, Kopkan L, Kikerlová S, Husková Z, Sadowski J, Kompanowska-Jezierska E, Hammock BD, Imig JD, Táborský M, Melenovský V, Červenka L.

Front Pharmacol. 2019 Jan 23;10:18. doi: 10.3389/fphar.2019.00018. eCollection 2019.

7.

Myocardial iron homeostasis and hepcidin expression in a rat model of heart failure at different levels of dietary iron intake.

Petrak J, Havlenova T, Krijt M, Behounek M, Franekova J, Cervenka L, Pluhacek T, Vyoral D, Melenovsky V.

Biochim Biophys Acta Gen Subj. 2019 Apr;1863(4):703-713. doi: 10.1016/j.bbagen.2019.01.010. Epub 2019 Jan 21.

PMID:
30677469
8.

Electrochemical Study and Determination of All-trans-Retinol at Carbon Paste Electrode Modified by a Surfactant.

Žabčíková S, Mikysek T, Červenka L, Sýs M.

Food Technol Biotechnol. 2018 Sep;56(3):337-343. doi: 10.17113/ftb.56.03.18.5618.

9.

The Role of Renal Vascular Reactivity in the Development of Renal Dysfunction in Compensated and Decompensated Congestive Heart Failure.

Kratky V, Kopkan L, Kikerlova S, Huskova Z, Taborsky M, Sadowski J, Kolar F, Cervenka L.

Kidney Blood Press Res. 2018;43(6):1730-1741. doi: 10.1159/000495391. Epub 2018 Nov 23.

10.

Kidney Response to Heart Failure: Proteomic Analysis of Cardiorenal Syndrome.

Melenovsky V, Cervenka L, Viklicky O, Franekova J, Havlenova T, Behounek M, Chmel M, Petrak J.

Kidney Blood Press Res. 2018;43(5):1437-1450. doi: 10.1159/000493657. Epub 2018 Sep 20.

11.

20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic rats.

Sedláková L, Kikerlová S, Husková Z, Červenková L, Chábová VČ, Zicha J, Falck JR, Imig JD, Kompanowska-Jezierska E, Sadowski J, Krátký V, Červenka L, Kopkan L.

Biosci Rep. 2018 Sep 12;38(5). pii: BSR20171496. doi: 10.1042/BSR20171496. Print 2018 Oct 31.

12.

Renoprotective effects of ET(A) receptor antagonists therapy in experimental non-diabetic chronic kidney disease: Is there still hope for the future?

Vaněčková I, Hojná S, Kadlecová M, Vernerová Z, Kopkan L, Červenka L, Zicha J.

Physiol Res. 2018 Jun 27;67(Supplementum 1):S55-S67. Review.

13.

Isovolumic loading of the failing heart by intraventricular placement of a spring expander attenuates cardiac atrophy after heterotopic heart transplantation.

Pokorný M, Mrázová I, Šochman J, Melenovský V, Malý J, Pirk J, Červenková L, Sadowski J, Čermák Z, Volenec K, Vacková Š, Maxová H, Červenka L, Netuka I.

Biosci Rep. 2018 Jun 27;38(3). pii: BSR20180371. doi: 10.1042/BSR20180371. Print 2018 Jun 29.

14.

Two pharmacological epoxyeicosatrienoic acid-enhancing therapies are effectively antihypertensive and reduce the severity of ischemic arrhythmias in rats with angiotensin II-dependent hypertension.

Červenka L, Husková Z, Kopkan L, Kikerlová S, Sedláková L, Vaňourková Z, Alánová P, Kolář F, Hammock BD, Hwang SH, Imig JD, Falck JR, Sadowski J, Kompanowska-Jezierska E, Neckář J.

J Hypertens. 2018 Jun;36(6):1326-1341. doi: 10.1097/HJH.0000000000001708.

PMID:
29570510
15.

Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease.

Čertíková Chábová V, Kujal P, Škaroupková P, Varňourková Z, Vacková Š, Husková Z, Kikerlová S, Sadowski J, Kompanowska-Jezierska E, Baranowska I, Hwang SH, Hammock BD, Imig JD, Tesař V, Červenka L.

Kidney Blood Press Res. 2018;43(2):329-349. doi: 10.1159/000487902. Epub 2018 Mar 6.

16.

Effect of angiotensin-converting enzyme blockade, alone or combined with blockade of soluble epoxide hydrolase, on the course of congestive heart failure and occurrence of renal dysfunction in Ren-2 transgenic hypertensive rats with aorto-caval fistula.

Kala P, Sedláková L, Škaroupková P, Kopkan L, Vaňourková Z, Táborský M, Nishiyama A, Hwang SH, Hammock BD, Sadowski J, Melenovský V, Imig JD, Červenka L.

Physiol Res. 2018 Jul 17;67(3):401-415. Epub 2018 Mar 12.

17.

Effects of increased myocardial tissue concentration of myristic, palmitic and palmitoleic acids on the course of cardiac atrophy of the failing heart unloaded by heterotopic transplantation.

Pokorný M, Mrázová I, Malý J, Pirk J, Netuka I, Vaňourková Z, Doleželová Š, Červenková L, Maxová H, Melenovský V, Šochman J, Sadowski J, Červenka L.

Physiol Res. 2018 Mar 16;67(1):13-30. Epub 2017 Nov 10.

18.

Fenofibrate Attenuates Hypertension in Goldblatt Hypertensive Rats: Role of 20-Hydroxyeicosatetraenoic Acid in the Nonclipped Kidney.

Sporková A, Čertíková Chábová V, Doleželová Š, Jíchová Š, Kopkan L, Vaňourková Z, Kompanowska-Jezierska E, Sadowski J, Maxová H, Červenka L.

Am J Med Sci. 2017 Jun;353(6):568-579. doi: 10.1016/j.amjms.2017.04.009. Epub 2017 Apr 12.

PMID:
28641720
19.
20.

Selective replacement of mitochondrial DNA increases the cardioprotective effect of chronic continuous hypoxia in spontaneously hypertensive rats.

Neckář J, Svatoňová A, Weissová R, Drahota Z, Zajíčková P, Brabcová I, Kolář D, Alánová P, Vašinová J, Šilhavý J, Hlaváčková M, Tauchmannová K, Milerová M, Ošťádal B, Červenka L, Žurmanová J, Kalous M, Nováková O, Novotný J, Pravenec M, Kolář F.

Clin Sci (Lond). 2017 May 1;131(9):865-881. doi: 10.1042/CS20170083. Epub 2017 Mar 14.

PMID:
28292971
21.

Renin-angiotensin system blockade alone or combined with ETA receptor blockade: effects on the course of chronic kidney disease in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.

Sedláková L, Čertíková Chábová V, Doleželová Š, Škaroupková P, Kopkan L, Husková Z, Červenková L, Kikerlová S, Vaněčková I, Sadowski J, Kompanowska-Jezierska E, Kujal P, Kramer HJ, Červenka L.

Clin Exp Hypertens. 2017;39(2):183-195. doi: 10.1080/10641963.2016.1235184. Epub 2017 Mar 1.

PMID:
28287881
22.

Fenofibrate Attenuates Malignant Hypertension by Suppression of the Renin-angiotensin System: A Study in Cyp1a1-Ren-2 Transgenic Rats.

Jíchová Š, Doleželová Š, Kopkan L, Kompanowska-Jezierska E, Sadowski J, Červenka L.

Am J Med Sci. 2016 Dec;352(6):618-630. doi: 10.1016/j.amjms.2016.09.008. Epub 2016 Sep 27.

PMID:
27916218
23.

Sensitive Voltammetric Determination of Natural Flavonoid Quercetin on a Disposable Graphite Lead.

Vu DL, Žabčíková S, Červenka L, Ertek B, Dilgin Y.

Food Technol Biotechnol. 2015 Dec;53(4):379-384.

25.

Quality and Antioxidant Activity of Buckwheat-Based Cookies Designed for a Raw Food Vegan Diet as Affected by Moderate Drying Temperature.

Brožková I, Dvořáková V, Michálková K, Červenka L, Velichová H.

Plant Foods Hum Nutr. 2016 Dec;71(4):429-435.

PMID:
27679438
26.

Progression of hypertension and kidney disease in aging fawn-hooded rats is mediated by enhanced influence of renin-angiotensin system and suppression of nitric oxide system and epoxyeicosanoids.

Doleželová Š, Jíchová Š, Husková Z, Vojtíšková A, Kujal P, Hošková L, Kautzner J, Sadowski J, Červenka L, Kopkan L.

Clin Exp Hypertens. 2016;38(7):644-651. Epub 2016 Sep 26.

PMID:
27669111
27.

Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.

Jíchová Š, Kopkan L, Husková Z, Doleželová Š, Neckář J, Kujal P, Vernerová Z, Kramer HJ, Sadowski J, Kompanowska-Jezierska E, Reddy RN, Falck JR, Imig JD, Červenka L.

J Hypertens. 2016 Oct;34(10):2008-25. doi: 10.1097/HJH.0000000000001029.

28.

Sex-linked differences in the course of chronic kidney disease and congestive heart failure: a study in 5/6 nephrectomized Ren-2 transgenic hypertensive rats with volume overload induced using aorto-caval fistula.

Červenka L, Škaroupková P, Kompanowska-Jezierska E, Sadowski J.

Clin Exp Pharmacol Physiol. 2016 Oct;43(10):883-95. doi: 10.1111/1440-1681.12619.

PMID:
27385471
29.

Interlobular Arteries From 2-Kidney, 1-Clip Goldblatt Hypertensive Rats' Exhibit-Impaired Vasodilator Response to Epoxyeicosatrienoic Acids.

Sporková A, Reddy RN, Falck JR, Imig JD, Kopkan L, Sadowski J, Červenka L.

Am J Med Sci. 2016 May;351(5):513-9. doi: 10.1016/j.amjms.2016.02.030. Epub 2016 Feb 23.

30.

Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.

Husková Z, Kopkan L, Červenková L, Doleželová Š, Vaňourková Z, Škaroupková P, Nishiyama A, Kompanowska-Jezierska E, Sadowski J, Kramer HJ, Červenka L.

Clin Exp Pharmacol Physiol. 2016 Apr;43(4):438-49. doi: 10.1111/1440-1681.12553.

PMID:
26833491
31.

Association of intima-media thickness of carotid arteries with remnant lipoproteins in men and women.

Piťha J, Kovář J, Škodová Z, Cífková R, Stávek P, Červenka L, Šejda T, Lánská V, Poledne R.

Physiol Res. 2015;64 Suppl 3:S377-84.

32.

Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats.

Alánová P, Husková Z, Kopkan L, Sporková A, Jíchová Š, Neckář J, Imig JD, Klevstig M, Kolář F, Rami Reddy N, Falck JR, Sadowski J, Nishiyama A, Kramer HJ, Melenovský V, Červenková L, Kujal P, Vernerová Z, Červenka L.

Vascul Pharmacol. 2015 Oct;73:45-56. doi: 10.1016/j.vph.2015.08.013. Epub 2015 Aug 22.

PMID:
26304700
33.

Conditional knockout of collecting duct bradykinin B2 receptors exacerbates angiotensin II-induced hypertension during high salt intake.

Kopkan L, Husková Z, Jíchová Š, Červenková L, Červenka L, Saifudeen Z, El-Dahr SS.

Clin Exp Hypertens. 2016;38(1):1-9. doi: 10.3109/10641963.2015.1047945. Epub 2015 Jul 7.

34.

High salt intake increases blood pressure in normal rats: putative role of 20-HETE and no evidence on changes in renal vascular reactivity.

Walkowska A, Kuczeriszka M, Sadowski J, Olszyñski KH, Dobrowolski L, Červenka L, Hammock BD, Kompanowska-Jezierska E.

Kidney Blood Press Res. 2015;40(3):323-34. doi: 10.1159/000368508. Epub 2015 May 31.

35.

Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula.

Červenka L, Melenovský V, Husková Z, Sporková A, Bürgelová M, Škaroupková P, Hwang SH, Hammock BD, Imig JD, Sadowski J.

Physiol Res. 2015;64(6):857-73. Epub 2015 Jun 5.

36.

Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.

Červenka L, Melenovský V, Husková Z, Škaroupková P, Nishiyama A, Sadowski J.

Clin Exp Pharmacol Physiol. 2015 Jul;42(7):795-807. doi: 10.1111/1440-1681.12419.

PMID:
25969338
37.

Hepatocyte transplantation attenuates the course of acute liver failure induced by thioacetamide in Lewis rats.

Koblihová E, Lukšan O, Mrázová I, Ryska M, Červenka L.

Physiol Res. 2015;64(5):689-700. Epub 2015 Mar 24.

38.

Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: studies in Cyp1a1-Ren-2 transgenic rats.

Sporková A, Jíchová S, Husková Z, Kopkan L, Nishiyama A, Hwang SH, Hammock BD, Imig JD, Kompanowska-Jezierska E, Sadowski J, Kramer HJ, Cervenka L.

Clin Exp Pharmacol Physiol. 2014 Dec;41(12):1003-13. doi: 10.1111/1440-1681.12310.

39.

Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.

Hampl V, Herget J, Bíbová J, Baňasová A, Husková Z, Vaňourková Z, Jíchová Š, Kujal P, Vernerová Z, Sadowski J, Červenka L.

Physiol Res. 2015;64(1):25-38. Epub 2014 Sep 5.

40.
41.

Ventricular assist devices in heart failure: how to support the heart but prevent atrophy?

Pokorný M, Cervenka L, Netuka I, Pirk J, Koňařík M, Malý J.

Physiol Res. 2014;63(2):147-56. Review.

42.

Tacrolimus-induced hypertension and nephrotoxicity in Fawn-Hooded rats are attenuated by dual inhibition of renin-angiotensin system.

Hošková L, Málek I, Kautzner J, Honsová E, van Dokkum RP, Husková Z, Vojtíšková A, Varcabová S, Cervenka L, Kopkan L.

Hypertens Res. 2014 Aug;37(8):724-32. doi: 10.1038/hr.2014.79. Epub 2014 Apr 10.

PMID:
24718302
43.

Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.

Kujal P, Čertíková Chábová V, Škaroupková P, Husková Z, Vernerová Z, Kramer HJ, Walkowska A, Kompanowska-Jezierska E, Sadowski J, Kitada K, Nishiyama A, Hwang SH, Hammock BD, Imig JD, Červenka L.

Clin Exp Pharmacol Physiol. 2014 Mar;41(3):227-37. doi: 10.1111/1440-1681.12204.

44.

Addition of ET(A) receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats.

Čertíková Chábová V, Vernerová Z, Kujal P, Husková Z, Škaroupková P, Tesař V, Kramer HJ, Kompanowska-Jezierska E, Walkowska A, Sadowski J, Červenka L, Vaněčková I.

Life Sci. 2014 Nov 24;118(2):297-305. doi: 10.1016/j.lfs.2013.12.018. Epub 2013 Dec 25.

45.

Effects of angiotensin II AT₁-receptor blockade on high fat diet-induced vascular oxidative stress and endothelial dysfunction in Dahl salt-sensitive rats.

Kosaka S, Pelisch N, Rahman M, Nakano D, Hitomi H, Kobori H, Fukuoka N, Kobara H, Mori H, Masaki T, Cervenka L, Matsumura Y, Houchi H, Nishiyama A.

J Pharmacol Sci. 2013;121(2):95-102. Epub 2013 Jan 22.

46.

Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME.

Honetschlägerová Z, Kitada K, Husková Z, Sporková A, Kopkan L, Bürgelová M, Varcabová Š, Nishiyama A, Hwang SH, Hammock BD, Imig JD, Kramer HJ, Kujal P, Vernerová Z, Červenka L.

J Hypertens. 2013 Feb;31(2):321-32. doi: 10.1097/HJH.0b013e32835b50aa.

47.
48.

Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system.

Varcabova S, Huskova Z, Kramer HJ, Hwang SH, Hammock BD, Imig JD, Kitada K, Cervenka L.

Clin Exp Pharmacol Physiol. 2013 Apr;40(4):273-81. doi: 10.1111/1440-1681.12018.

49.

Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension.

Kopkan L, Husková Z, Sporková A, Varcabová Š, Honetschlägerová Z, Hwang SH, Tsai HJ, Hammock BD, Imig JD, Kramer HJ, Bürgelová M, Vojtíšková A, Kujal P, Vernerová Z, Červenka L.

Kidney Blood Press Res. 2012;35(6):595-607. doi: 10.1159/000339883. Epub 2012 Aug 29.

50.

Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats.

Vaněčková I, Kujal P, Husková Z, Vaňourková Z, Vernerová Z, Certíková Chábová V, Skaroupková P, Kramer HJ, Tesař V, Červenka L.

Kidney Blood Press Res. 2012;35(5):382-92. doi: 10.1159/000336823. Epub 2012 Apr 4.

Supplemental Content

Loading ...
Support Center